US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 22.060
  • -0.020-0.09%
Close May 13 16:00 ET
  • 22.060
  • 0.0000.00%
Post 16:20 ET
2.74BMarket Cap-5215P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Arrowhead Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings Estimates

May 9, 2024

Revenue(YoY)

56.83M

-61.15%
EPS(YoY)

-0.22

-148.29%

Buy

May 13, 2024

Arrowhead Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20242024/Q4-- / 53.085M--
--2024/Q3-- / 30.468M--
May 9, 20242024/Q20.000 / 56.830M--
--2024/Q13.551M / 29.636M--
Nov 29, 20232023/Q416.097M / 46.967M--
Aug 7, 20232023/Q315.825M / 45.423M--
May 2, 20232023/Q2146.267M / 45.479M--
Feb 6, 20232023/Q162.546M / 162.517M--
Nov 28, 20222022/Q431.575M / 91.206M--
Aug 4, 20222022/Q332.412M / 52.607M--
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20242024/Q4-- / 53.085M--
--2024/Q3-- / 30.468M--
May 9, 20242024/Q20.000 / 56.830M--
--2024/Q13.551M / 29.636M--
Nov 29, 20232023/Q416.097M / 46.967M--
Aug 7, 20232023/Q315.825M / 45.423M--
May 2, 20232023/Q2146.267M / 45.479M--
Feb 6, 20232023/Q162.546M / 162.517M--
Nov 28, 20222022/Q431.575M / 91.206M--
Aug 4, 20222022/Q332.412M / 52.607M--

Unlock Free Earnings Estimates

Arrowhead Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 13, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg